Concepedia

Jörn Weisner

JW

Statistics

Publications

11

Citations

577

H-Index

11

Active since

2015

Affiliations

TU Dortmund University(Current)

German Cancer Research Center

Lead Discovery Center (Germany)

Deutsches Konsortium für Translationale Krebsforschung

Max Planck Institute of Molecular Physiology

Jörn Weisner is an author at TU Dortmund University specializing in ligand binding, drug discovery, and drug design.

ORCID

Publications per year

2015–2024

11

Publications

11

Covalent‐Allosteric Kinase Inhibitors

Jörn Weisner, Rajesh Gontla, Leandi Van Der Westhuizen et al. · Angewandte Chemie International Edition · 2015 · 113 citations

, , +17

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal Cancer

Jörn Weisner, Ina Landel, Christoph Reintjes et al. · Cancer Research · 2019 · 91 citations

, , +17

2-Azo-, 2-diazocine-thiazols and 2-azo-imidazoles as photoswitchable kinase inhibitors: limitations and pitfalls of the photoswitchable inhibitor approach

Miriam Schehr, Chiara Lanes, Jörn Weisner et al. · Photochemical & Photobiological Sciences · 2019 · 76 citations

, , +11

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Lena Quambusch, Ina Landel, Laura Depta et al. · Angewandte Chemie International Edition · 2019 · 71 citations · Full text

, , +17

Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt

Niklas Uhlenbrock, Steven P. Smith, Jörn Weisner et al. · Chemical Science · 2019 · 70 citations · Full text

, , +17

1–5 of 11